Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Dermatologie (Heidelberg, Germany)
|
January 23, 2023
[Clinical and diagnostic features of skin cancer on darker skin]
Ephsona Shencoru, Max Schlaak
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 6, 2009
Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study
Max Schlaak, Jan C Simon
ALTEX
|
January 1, 1995
[In vitro cultivation of Brugia malayi, a parasitic nematode that causes human lymphatic filariasis]
Franco H. Falcone, Max Schlaak, Helmut Haas
The Journal of Dermatology
|
August 11, 2018
Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis
Oana-Diana Persa, Jana Knuever, Cornelia Mauch, et al.
International Journal of Dermatology
|
September 20, 2018
Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients
Oana-Diana Persa, Jana Knuever, Anna Rose, et al.
Clinical Nuclear Medicine
|
September 22, 2012
68Ga-DOTATATE-PET/CT positive metastatic lymph node in a 69-year-old woman with Merkel cell carcinoma
Christina Schneider, Max Schlaak, Marc Bludau, et al.
Oncology Research and Treatment
|
June 15, 2025
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study
Jana Knuever, Oana-Diana Persa, Lukas Gerecht, et al.
Oncology Research and Treatment
|
April 20, 2017
Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation
Katharina Leuchte, Max Schlaak, Rudolf Stadler, et al.
Oncotarget
|
February 1, 2012
Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells
Max Schlaak, Patrick Schmidt, Christopher Bangard, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2018
[Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts]
Max Schlaak, Christian Baues, Maike Trommer-Nestler, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Dermatologie (Heidelberg, Germany)
|
January 23, 2023
[Clinical and diagnostic features of skin cancer on darker skin]
Ephsona Shencoru, Max Schlaak
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 6, 2009
Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study
Max Schlaak, Jan C Simon
ALTEX
|
January 1, 1995
[In vitro cultivation of Brugia malayi, a parasitic nematode that causes human lymphatic filariasis]
Franco H. Falcone, Max Schlaak, Helmut Haas
The Journal of Dermatology
|
August 11, 2018
Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis
Oana-Diana Persa, Jana Knuever, Cornelia Mauch, et al.
International Journal of Dermatology
|
September 20, 2018
Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients
Oana-Diana Persa, Jana Knuever, Anna Rose, et al.
Clinical Nuclear Medicine
|
September 22, 2012
68Ga-DOTATATE-PET/CT positive metastatic lymph node in a 69-year-old woman with Merkel cell carcinoma
Christina Schneider, Max Schlaak, Marc Bludau, et al.
Oncology Research and Treatment
|
June 15, 2025
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study
Jana Knuever, Oana-Diana Persa, Lukas Gerecht, et al.
Oncology Research and Treatment
|
April 20, 2017
Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation
Katharina Leuchte, Max Schlaak, Rudolf Stadler, et al.
Oncotarget
|
February 1, 2012
Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells
Max Schlaak, Patrick Schmidt, Christopher Bangard, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2018
[Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts]
Max Schlaak, Christian Baues, Maike Trommer-Nestler, et al.
Page
of 10